Literature DB >> 21621344

Vasculatures in tumors growing from preirradiated tissues: formed by vasculogenesis and resistant to radiation and antiangiogenic therapy.

Fang-Hsin Chen1, Chi-Shiun Chiang, Chun-Chieh Wang, Sheng-Yung Fu, Chien-Sheng Tsai, Shih-Ming Jung, Chih-Jen Wen, Chung-Chi Lee, Ji-Hong Hong.   

Abstract

PURPOSE: To investigate vasculatures and microenvironment in tumors growing from preirradiated tissues (pre-IR tumors) and study the vascular responses of pre-IR tumors to radiation and antiangiogenic therapy. METHODS AND MATERIALS: Transgenic adenocarcinoma of the mouse prostate C1 tumors were implanted into unirradiated or preirradiated tissues and examined for vascularity, hypoxia, and tumor-associated macrophage (TAM) infiltrates by immunohistochemistry. The origin of tumor endothelial cells was studied by green fluorescent protein-tagged bone marrow (GFP-BM) transplantation. The response of tumor endothelial cells to radiation and antiangiogenic agent was evaluated by apoptotic assay.
RESULTS: The pre-IR tumors had obvious tumor bed effects (TBE), with slower growth rate, lower microvascular density (MVD), and more necrotic and hypoxic fraction compared with control tumors. The vessels were dilated, tightly adhered with pericytes, and incorporated with transplanted GFP-BM cells. In addition, hypoxic regions became aggregated with TAM. As pre-IR tumors developed, the TBE was overcome at the tumor edge where the MVD increased, TAM did not aggregate, and the GFP-BM cells did not incorporate into the vessels. The vessels at tumor edge were more sensitive to the following ionizing radiation and antiangiogenic agent than those in the central low MVD regions.
CONCLUSIONS: This study demonstrates that vasculatures in regions with TBE are mainly formed by vasculogenesis and resistant to radiation and antiangiogenic therapy. Tumor bed effects could be overcome at the edge of larger tumors, but where vasculatures are formed by angiogenesis and sensitive to both treatments. Vasculatures formed by vasculogenesis should be the crucial target for the treatment of recurrent tumors after radiotherapy.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21621344     DOI: 10.1016/j.ijrobp.2011.02.055

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

1.  Sunitinib Treatment-elicited Distinct Tumor Microenvironment Dramatically Compensated the Reduction of Myeloid-derived Suppressor Cells.

Authors:  Sheng-Yung Fu; Chun-Chieh Wang; Fang-Hsin Chen; Ching-Fang Yu; Ji-Hong Hong; Chi-Shiun Chiang
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Improved sensitization effect of sunitinib in cancer cells of the esophagus under hypoxic microenviroment.

Authors:  Yu-Qiong Ding; Qin Qin; Yan Yang; Xin-Chen Sun; Xi Yang; Hong-Cheng Zhu; Xiao-Chen Chen; Hao Zhang; Yue-Hua Yang; Lei Gao; Ju-Dong Luo; Xi-Fa Zhou
Journal:  Oncol Lett       Date:  2016-10-13       Impact factor: 2.967

Review 3.  Radiation and inflammation.

Authors:  Dörthe Schaue; Ewa D Micewicz; Josephine A Ratikan; Michael W Xie; Genhong Cheng; William H McBride
Journal:  Semin Radiat Oncol       Date:  2015-01       Impact factor: 5.934

Review 4.  Hijacking the vasculature in ccRCC--co-option, remodelling and angiogenesis.

Authors:  Chao-Nan Qian
Journal:  Nat Rev Urol       Date:  2013-03-05       Impact factor: 14.432

Review 5.  Cytokines in radiobiological responses: a review.

Authors:  Dörthe Schaue; Evelyn L Kachikwu; William H McBride
Journal:  Radiat Res       Date:  2012-10-29       Impact factor: 2.841

6.  The irradiated tumor microenvironment: role of tumor-associated macrophages in vascular recovery.

Authors:  Jeffery S Russell; J Martin Brown
Journal:  Front Physiol       Date:  2013-07-17       Impact factor: 4.566

7.  Irradiation promotes an m2 macrophage phenotype in tumor hypoxia.

Authors:  Chi-Shiun Chiang; Sheng Yung Fu; Shu-Chi Wang; Ching-Fang Yu; Fang-Hsin Chen; Chi-Min Lin; Ji-Hong Hong
Journal:  Front Oncol       Date:  2012-08-06       Impact factor: 6.244

8.  Irradiation Enhances the Ability of Monocytes as Nanoparticle Carrier for Cancer Therapy.

Authors:  Pei-Shin Jiang; Ching-Fang Yu; Chia-Yi Yen; Christopher William Woo; Shao-Hua Lo; Yu-Kuan Huang; Ji-Hong Hong; Chi-Shiun Chiang
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

9.  Breast cancer causes and treatment: where are we going wrong?

Authors:  Colin B Seymour; Carmel Mothersill
Journal:  Breast Cancer (Dove Med Press)       Date:  2013-12-03

Review 10.  Radiotherapy and the tumor stroma: the importance of dose and fractionation.

Authors:  Turid Hellevik; Iñigo Martinez-Zubiaurre
Journal:  Front Oncol       Date:  2014-01-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.